$CRSP News Article - CRISPR Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to CTX130(TM) for the Treatment of Cutaneous T-Cell Lymphomas (CTCL) https://marketwirenews.com/news-releases/cris...69007.html
(0)
(0)
CRISPR Therapeutics AG (CRSP) Stock Research Links